REGENERON PHARMACEUTICALS

About

Regeneron Pharmaceuticals is a biotechnology company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. The company is known for its expertise in monoclonal antibodies and maintains a diverse portfolio focused on ophthalmology, oncology, and inflammatory diseases. Regeneron holds a significant market position through key products like Eylea and Dupixent, which are established leaders in their respective therapeutic areas.